We are excited to announce that effective September 1, 2013, SABio opened its new laboratory and office at the Innovation Centre at Nanyang Technological University (NTU). We are looking forward to further growing in the vibrant Innovation Centre incubator environment with ample possibilities for interactions with innovative biotech, medtech, engineering and IT companies started by NTU students.
Since relocation, we have closed our former lab at SingHealth Research Facilities at Outram Park. We will warmly remember our stay at the SingHealth lab, where SABio has matured into a reputable home-grown biologic reagents producer. SABio started its operations there 2.5 years ago, and our first products were synthetic oligonucleotides and siRNA, which were beta-tested by SingHealth and Duke-NUS laboratories. They later became loyal and supportive customers. SABio has also further expanded its biologics offerings by introducing catalogue antibodies, custom antibody production services, and synthetic peptides. The RNA product spectrum has also grown, as new products and custom protocols were developed by our R&D team.
Upon relocation to NTU, SABio continues its R&D projects in RNA and antibody field incepted over the last two years, and is constantly on a look out for new opportunities to grow its innovations, technology and business. Here at NTU we foresee further opportunities for collaborations and partnerships, while will continue fostering valuable relationships we developed during our stay at the vicinity of SingHealth, NCCS, and Duke-NUS.
Since relocation, we have closed our former lab at SingHealth Research Facilities at Outram Park. We will warmly remember our stay at the SingHealth lab, where SABio has matured into a reputable home-grown biologic reagents producer. SABio started its operations there 2.5 years ago, and our first products were synthetic oligonucleotides and siRNA, which were beta-tested by SingHealth and Duke-NUS laboratories. They later became loyal and supportive customers. SABio has also further expanded its biologics offerings by introducing catalogue antibodies, custom antibody production services, and synthetic peptides. The RNA product spectrum has also grown, as new products and custom protocols were developed by our R&D team.
Upon relocation to NTU, SABio continues its R&D projects in RNA and antibody field incepted over the last two years, and is constantly on a look out for new opportunities to grow its innovations, technology and business. Here at NTU we foresee further opportunities for collaborations and partnerships, while will continue fostering valuable relationships we developed during our stay at the vicinity of SingHealth, NCCS, and Duke-NUS.
RSS Feed
